Introduction Maternal and child mortality has markedly decreased worldwide over the past few decades. Despite this success, the decline remains unequal across countries and is overall insufficient to ...

AAVantgarde and AGC Biologics collaborate to manufacture dual-vector gene therapies for inherited retinal disorders, AAVB-039 and AAVB-081. AAVantgarde secured $141 million in Series B funding to ...

This submission is currently being researched & evaluated! You can help confirm this entry by contributing facts, media, and other evidence of notability and mutation. On July 24th, 2025, X [2] user ...

AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease" Collaboration will leverage AGC Biologics’ commercial manufacturing experience and proven platforms ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

AGC Television, the scripted television production and distribution division of Stuart Ford’s AGC Studios, is adding “A Wolf’s Prey” to its distribution slate and introducing the six episode ...

An aerial view of the AGC Biologics plant in Longmont. It plans to lay off nearly 300 workers in Boulder County as the contract pharmaceutical manufacturer attempts to sell its factories in Longmont ...

If you canceled your payment, click here to close this window. If you processed a payment and this page does not reload in 10 seconds, please reach out to Bruce Dennis at 303-630-1953 for additional ...

Manufacturing excellence positions Seattle site as premier destination for mammalian and microbial biologic production in thriving Pacific Northwest life sciences hub SEATTLE--(BUSINESS WIRE)--AGC ...

This study analyses the experience of integrating sustainable development modules into the curricula of two Kazakh universities. Unlike most Western models, the project is adapted to the conditions of ...

AGC Biologics’ Seattle manufacturing facility has reached significant milestones in 2025, reinforcing its role as a key player in the biopharmaceutical industry. The site successfully completed a ...

TOKYO--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical ...